Transfected human dendritic cells as cancer vaccines
- 1 April 1998
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 16 (4) , 335-336
- https://doi.org/10.1038/nbt0498-335
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNANature Biotechnology, 1998
- Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLsNature, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- DNA VACCINESAnnual Review of Immunology, 1997
- Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.The Journal of Experimental Medicine, 1996
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994